Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alcohol and hepatitis C.

Kamran Safdar1, Eugene R Schiff

  • 1Center for Liver Diseases, Division of Hepatology, Department of Medicine, University of Miami, Miami, Florida 33136, USA.

Seminars in Liver Disease
|September 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isochromophilones H-K, the new bioactive azaphilone derivatives isolated from fungal strain Diaporthe perseae associated with Pongamia pinnata plant.

Microbial pathogenesis·2024
Same author

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.

JHEP reports : innovation in hepatology·2024
Same author

Characterisation of the essential oil from <i>Iphiona grantioides</i> and investigation of its antibacterial and antioxidant properties.

Natural product research·2023
Same author

Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.

Journal of hepatology·2022
Same author

Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.

Journal of hepatology·2022
Same author

Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients.

Annals of surgery·2021
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Alcohol abuse worsens chronic liver disease in hepatitis C virus (HCV) patients, accelerating fibrosis and increasing cancer risk. Complete alcohol abstinence is crucial for better outcomes and treatment response in individuals with HCV infection.

Area of Science:

  • Hepatology
  • Virology
  • Toxicology

Background:

  • Alcohol abuse and hepatitis C virus (HCV) infection frequently coexist in patients with chronic liver disease.
  • The combined injury mechanism is multifactorial, involving immune dysfunction, oxidative stress, and increased apoptosis.

Purpose of the Study:

  • To elucidate the detrimental effects of alcohol consumption in patients with HCV infection.
  • To emphasize the necessity of alcohol abstinence for managing HCV-related liver disease.

Main Methods:

  • Review of existing literature on the synergistic effects of alcohol and HCV on liver injury.
  • Analysis of clinical outcomes in patients with coexisting alcohol abuse and HCV infection.

Main Results:

Related Experiment Videos

  • Alcohol consumption accelerates liver fibrosis progression, increases cirrhosis frequency, and elevates hepatocellular carcinoma (HCC) incidence in HCV patients.
  • Co-infection leads to decreased survival rates compared to single conditions.
  • Alcohol abuse diminishes response to interferon treatment in HCV patients.

Conclusions:

  • Alcohol consumption significantly exacerbates liver disease progression and reduces survival in HCV-infected individuals.
  • Complete alcohol abstinence is strongly recommended for all patients with HCV infection to improve treatment efficacy and long-term prognosis.